Italy Proton Therapy Market to See Robust Growth, States Renub Research in Its In-demand Study Available at MarketPublishers.com
04 Apr 2017 • by Natalie Aster
LONDON – Italy’s proton therapy market is expected to double in 2021 from the market of 2016. To date, there are 3 proton beam therapy centers in the country, which considerably boosts their capacity to treat a greater number of patients. The treatment of the first local patients with proton beams was administered in 2002 at Catania’s INFN-LNS. Surging incidence rates of cancer patients in Italy, and technological advances are expected to give a boost to the domestic proton therapy marketplace. However, need for massive investments and various operations challenges could hinder the market growth in the offing.
Varian Medical Systems, IBA, and Elekta are amid the leading players in the country’s proton therapy marketplace.
In-demand market research report “Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast” created by Renub Research gives an all-round assessment of the proton therapy industry on a national level.
The study examines the current market performance and speculates on the potential market which can possibly achieved in the offing.
The report provides comprehensive data on the actual and potential market size and forecasts from 2009 and through to 2021. It casts light on the volume of treated patients with proton beams plus forecasts as well as analyses the proton therapy potential patient volumes and forecast figures. The research publication includes a detailed listing of all operational and projected proton therapy centers, and sheds light on the reimbursement policies. Furthermore, the report gives deep insights into the top 3 market players and gives detailed data on proton therapy revenues. Additionally, the study offers an insightful analysis of the drivers and challenges with respect to the market.
More topical market research reports by Renub Research can be found at its page.